Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Sell
48
ADGM Quote, Financials, Valuation and Earnings
Last price:
$1.01
Seasonality move
:
10.19%
Day range:
$0.88 - $0.97
52-week range:
$0.63 - $2.87
Dividend yield:
0%
P/E ratio:
218.00x
P/S ratio:
104.09x
P/B ratio:
1.99x
Volume:
44.3K
Avg. volume:
242.4K
1-year change:
13.55%
Market cap:
$19.7M
Revenue:
$602K
EPS (TTM):
-$5.28
Analysts' Opinion
-
Consensus RatingAdagio Medical Holdings, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.00, Adagio Medical Holdings, Inc. has an estimated upside of 330.11% from its current price of $0.93.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $0.93.
Fair Value
-
According to the consensus of 1 analyst, Adagio Medical Holdings, Inc. has 330.11% upside to fair value with a price target of $4.00 per share.
ADGM vs. S&P 500
-
Over the past 5 trading days, Adagio Medical Holdings, Inc. has overperformed the S&P 500 by 6.22% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Adagio Medical Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Adagio Medical Holdings, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Adagio Medical Holdings, Inc. reported revenues of --.
Earnings Growth
-
Adagio Medical Holdings, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Adagio Medical Holdings, Inc. reported earnings per share of -$0.66.
Enterprise value:
37M
EV / Invested capital:
--
Price / LTM sales:
104.09x
EV / EBIT:
--
EV / Revenue:
270.01x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.57x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$2.6M
Return On Assets:
-148.69%
Net Income Margin (TTM):
-57771.53%
Return On Equity:
-340.49%
Return On Invested Capital:
-193.23%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $222K | $465K | $137K | $185K | -- | |
| Gross Profit | -$750K | -$1.3M | -$2.6M | -$386K | -$531K | |
| Operating Income | -$22.9M | -$28.9M | -$26.7M | -$10.6M | -$5.7M | |
| EBITDA | -$22.5M | -$28M | -$25.2M | -$10.4M | -$5.2M | |
| Diluted EPS | -$35.26 | -$17.32 | -$5.28 | -$0.32 | -$0.66 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1M | $174K | $171.4K | $35M | $8.1M | |
| Total Assets | $150.6M | $150.6M | $39.8M | $107.2M | $31.5M | |
| Current Liabilities | $5.1M | $6M | $9.3M | $7.9M | $9.7M | |
| Total Liabilities | $10.3M | $8.6M | $11.9M | $30.6M | $32.9M | |
| Total Equity | $140.3M | $142M | $27.9M | $76.6M | -$1.3M | |
| Total Debt | -- | -- | -- | $13.8M | $21.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$40.5M | -$4.5M | -$22M | -$8.7M | -$3M | |
| Cash From Investing | -$820K | $113M | -$1.6M | -$609K | -$520K | |
| Cash From Financing | $24.9M | -$112.7M | -- | $990K | -- | |
| Free Cash Flow | -$41.4M | -$5.1M | -$23.6M | -$9.3M | -$3.5M | |
ADGM
Sector
Market Cap
$19.7M
$26M
Price % of 52-Week High
32.4%
51.81%
Dividend Yield
0%
0%
Shareholder Yield
76.43%
-1.66%
1-Year Price Total Return
13.55%
-18.29%
Beta (5-Year)
--
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.90
200-day SMA
Sell
Level
$1.28
Bollinger Bands (100)
Sell
Level
0.84 - 1.72
Chaikin Money Flow
Sell
Level
-16.1M
20-day SMA
Sell
Level
$0.97
Relative Strength Index (RSI14)
Sell
Level
47.93
ADX Line
Buy
Level
24.65
Williams %R
Neutral
Level
-60.7143
50-day SMA
Buy
Level
$0.92
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
133.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.5184)
Sell
CA Score
(Annual)
Level (-3.9214)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (9.8855)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.
Stock Forecast FAQ
In the current month, ADGM has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ADGM average analyst price target in the past 3 months is $4.00.
-
Where Will Adagio Medical Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Adagio Medical Holdings, Inc. share price will rise to $4.00 per share over the next 12 months.
-
What Do Analysts Say About Adagio Medical Holdings, Inc.?
Analysts are divided on their view about Adagio Medical Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Adagio Medical Holdings, Inc. is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is Adagio Medical Holdings, Inc.'s Price Target?
The price target for Adagio Medical Holdings, Inc. over the next 1-year time period is forecast to be $4.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ADGM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Adagio Medical Holdings, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of ADGM?
You can purchase shares of Adagio Medical Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Adagio Medical Holdings, Inc. shares.
-
What Is The Adagio Medical Holdings, Inc. Share Price Today?
Adagio Medical Holdings, Inc. was last trading at $1.01 per share. This represents the most recent stock quote for Adagio Medical Holdings, Inc.. Yesterday, Adagio Medical Holdings, Inc. closed at $0.93 per share.
-
How To Buy Adagio Medical Holdings, Inc. Stock Online?
In order to purchase Adagio Medical Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ADGM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ADGM
Sector
P/E ratio
218.00x
23.85x
PEG ratio
--
-0.01x
P/B ratio
1.99x
1.83x
Price / LTM sales
104.09x
1.56x
Growth Metrics
ADGM
Sector
Revenue growth
-100%
4.18%
Earnings growth
-106.53%
9.66%
Revenue (5-year growth)
--
6.28%
Earnings forecast
-$0.31
-$0.18
Profitability
ADGM
Sector
Profitability FY 2024
-$2.7M
$3.1M
Return on invested capital
-193.23%
-32.89%
Return on assets
-148.69%
-29.56%
Return on equity
-340.49%
-38.66%
Earnings Date
Last Earnings Date
Jan
23
Next Earnings Date
Jan
23
Estimated Next Earnings Date
Apr
24
Balance Sheet
ADGM
Sector
Total cash
$4.7M
$25.2M
Short term investments
--
$25.1M
Total assets
$50.2M
$73M
Long term debt
$21.8M
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
69
INTC alert for Jan 23
Intel Corp. [INTC] is down 17.73% over the past day.
Buy
51
APGE alert for Jan 23
Apogee Therapeutics, Inc. [APGE] is down 10.56% over the past day.
Buy
70
BNR alert for Jan 23
Burning Rock Biotech Ltd. [BNR] is down 14.05% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
